Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Otto Cars

Showing results (11-20 of 112) with videos related to

Pageof 12
Sort By:
Antimicrobial Agents and Chemotherapy|November 19, 2002
New automated method for determining postantifungal effect of amphotericin B against Candida species: effects of concentration, exposure time, and area under the curveErja Chryssanthou, Otto Cars, Jan Sjölin
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 30, 2011
The global need for effective antibiotics-moving towards concerted actionOtto Cars, Anna Hedin, Andreas Heddini
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 1, 1997
Comparative in vitro pharmacodynamics of BO-2727, meropenem and imipenem against Gram-positive and Gram-negative bacteriaInga Odenholt, Elisabeth Löwdin, Otto Cars
BMJ (Clinical Research Ed.)|September 25, 2024
The 2024 political declaration on antimicrobial resistance needs bold targetsViroj Tangcharoensathien, Otto Cars, Angkana Lekagul
The Journal of Antimicrobial Chemotherapy|November 26, 2004
Pharmacodynamic studies of amoxicillin against Streptococcus pneumoniae: comparison of a new pharmacokinetically enhanced formulation (2000 mg twice daily) with standard dosage regimensInga Odenholt, Otto Cars, Elisabeth Löwdin
Antimicrobial Agents and Chemotherapy|September 25, 2003
Postantibiotic, postantibiotic sub-MIC, and subinhibitory effects of PGE-9509924, ciprofloxacin, and levofloxacinInga Odenholt, Elisabeth Löwdin, Otto Cars
Lakartidningen|January 19, 2006
[Quinolones--a cure which became a threat. Accelerating resistance development demands stricter indications]Birgitta Lytsy, Otto Cars, Erik Torell
Antimicrobial Agents and Chemotherapy|July 11, 2007
Pharmacodynamic effects of telavancin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains in the presence of human albumin or serum and in an in vitro kinetic modelInga Odenholt, Elisabeth Löwdin, Otto Cars
International Journal of Antimicrobial Agents|August 6, 2015
Antibiotic resistance: An ethical challengeJasper Littmann, Alena Buyx, Otto Cars
The Journal of Antimicrobial Chemotherapy|July 17, 2003
Fitness of antibiotic resistant Staphylococcus epidermidis assessed by competition on the skin of human volunteersIngegerd Gustafsson, Otto Cars, Dan I Andersson
Pageof 12

Showing results (11-20 of 112) with videos related to

Sort By:
Pageof 12
Antimicrobial Agents and Chemotherapy|November 19, 2002
New automated method for determining postantifungal effect of amphotericin B against Candida species: effects of concentration, exposure time, and area under the curveErja Chryssanthou, Otto Cars, Jan Sjölin
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 30, 2011
The global need for effective antibiotics-moving towards concerted actionOtto Cars, Anna Hedin, Andreas Heddini
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 1, 1997
Comparative in vitro pharmacodynamics of BO-2727, meropenem and imipenem against Gram-positive and Gram-negative bacteriaInga Odenholt, Elisabeth Löwdin, Otto Cars
BMJ (Clinical Research Ed.)|September 25, 2024
The 2024 political declaration on antimicrobial resistance needs bold targetsViroj Tangcharoensathien, Otto Cars, Angkana Lekagul
The Journal of Antimicrobial Chemotherapy|November 26, 2004
Pharmacodynamic studies of amoxicillin against Streptococcus pneumoniae: comparison of a new pharmacokinetically enhanced formulation (2000 mg twice daily) with standard dosage regimensInga Odenholt, Otto Cars, Elisabeth Löwdin
Antimicrobial Agents and Chemotherapy|September 25, 2003
Postantibiotic, postantibiotic sub-MIC, and subinhibitory effects of PGE-9509924, ciprofloxacin, and levofloxacinInga Odenholt, Elisabeth Löwdin, Otto Cars
Lakartidningen|January 19, 2006
[Quinolones--a cure which became a threat. Accelerating resistance development demands stricter indications]Birgitta Lytsy, Otto Cars, Erik Torell
Antimicrobial Agents and Chemotherapy|July 11, 2007
Pharmacodynamic effects of telavancin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains in the presence of human albumin or serum and in an in vitro kinetic modelInga Odenholt, Elisabeth Löwdin, Otto Cars
International Journal of Antimicrobial Agents|August 6, 2015
Antibiotic resistance: An ethical challengeJasper Littmann, Alena Buyx, Otto Cars
The Journal of Antimicrobial Chemotherapy|July 17, 2003
Fitness of antibiotic resistant Staphylococcus epidermidis assessed by competition on the skin of human volunteersIngegerd Gustafsson, Otto Cars, Dan I Andersson
Pageof 12